🇺🇸 FDA
Patent

US 11033560

Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

granted A61KA61K31/675A61K31/683

Quick answer

US patent 11033560 (Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/675, A61K31/683, A61K45/06, A61P